Physician profile
Connie Lee
NPI 1457670465
$1,886.38
in general payments reported to CMS, 2019-2025
21 companies · $790 in 2025
The $790 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $87.87 · 2021: $143 · 2022: $43.12 · 2023: $352 · 2024: $144 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,285.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vector Surgical, LLC | $561.90 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $179.84 | 2024-2025 | Keytruda, Lynparza |
| Elucent Medical | $175.64 | 2025 | |
| Medtronic, INC. | $133.29 | 2022-2025 | Interstim |
| Novartis Pharmaceuticals Corporation | $120.74 | 2019-2025 | |
| Lilly USA, LLC | $102.93 | 2019-2025 | Jaypirca, Verzenio |
| Pfizer INC. | $98.65 | 2024 | |
| Puma Biotechnology, INC. | $95.41 | 2021-2025 | Nerlynx |
| Astrazeneca Pharmaceuticals LP | $62.39 | 2025 | Lynparza, Enhertu |
| Amgen INC. | $59.72 | 2020-2021 | |
| Daiichi Sankyo INC. | $49.02 | 2024-2025 | Enhertu |
| E.R. Squibb & Sons, L.L.C. | $42.27 | 2019-2021 | |
| Dilon Technologies, INC. | $42.08 | 2023 | Hemoblast Bellows |
| Bayer Healthcare Pharmaceuticals INC. | $31.94 | 2020-2021 | |
| Abbvie INC. | $27.26 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.21 | 2023 | Pico 7, Renasys Go V2 Home |
| Genentech USA, INC. | $18.86 | 2021 | |
| Seagen INC. | $17.89 | 2021 | |
| Immunomedics, INC. | $16.53 | 2020 | |
| Taiho Oncology, INC. | $14.55 | 2021 | |
| Eisai INC. | $14.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connie Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.